Association of provider HPV vaccination training with provider assessment of HPV vaccination status and recommendation of HPV vaccination.


Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
30 Nov 2022
Historique:
pubmed: 21 10 2022
medline: 15 12 2022
entrez: 20 10 2022
Statut: ppublish

Résumé

The delivery of strong HPV vaccine recommendations hinges on the expertise of healthcare providers (HCPs) in assessing patients' status and recommending HPV vaccination. We conducted a population-based cross-sectional study of HCPs practicing in Texas to examine the relationship between HPV vaccination training of HCPs and HPV vaccination status assessment and recommendation. Logistic regression analyses were used to assess the association between HCPs' formal training and recency of training in HPV vaccination promotion or counseling with HPV vaccination status assessment and recommendation. Of the 1,283 HCPs who completed the online survey, 43% had received training in HPV vaccination promotion or counseling, 47% often/always assess HPV vaccination status, and 59% often/always recommend HPV vaccination. Compared with HCPs who received no training, those who received training had over four times higher odds (adjusted odds ratio [AOR]: 4.32; 95% CI: 3.06-6.10) of often/always assessing HPV vaccination status and over three and half times higher odds (AOR: 3.66; 95% CI: 2.73-4.90) of often/always recommending HPV vaccination. Furthermore, HCPs who recently received HPV vaccination training had higher odds of HPV vaccination status assessment and recommendations than those without training. Hispanic HCPs had higher odds of often/always assessing HPV vaccination status and recommending vaccination than did non-Hispanic White HCPs. Also, nurses and physician assistants had lower odds of often/always assessing HPV vaccination status and recommending HPV vaccination than did physicians. Targeted and continuous training of HCPs in HPV vaccination promotion or counseling is needed to increase HPV vaccination status assessment, recommendation, and uptake rates.

Identifiants

pubmed: 36265005
doi: 10.1080/21645515.2022.2132755
pmc: PMC9746413
doi:

Substances chimiques

Papillomavirus Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2132755

Subventions

Organisme : NIAID NIH HHS
ID : L30 AI126518
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI150685
Pays : United States

Références

JAMA Pediatr. 2014 Jan;168(1):76-82
pubmed: 24276343
Vaccine X. 2019 Aug 05;3:100037
pubmed: 31463471
Fam Med. 2017 Oct;49(9):714-722
pubmed: 29045989
Vaccine. 2016 Feb 24;34(9):1187-92
pubmed: 26812078
Vaccine. 2011 Jan 29;29(5):890-5
pubmed: 20056186
Int J Cancer. 2017 Aug 15;141(4):664-670
pubmed: 28369882
Pediatrics. 2021 Jun;147(6):
pubmed: 33941585
Vaccine. 2012 Sep 14;30(42):6016-9
pubmed: 22867718
Health Educ Res. 2020 Dec 23;35(6):512-523
pubmed: 32879948
Vaccine. 2020 May 22;38(25):4119-4124
pubmed: 32349907
Vaccines (Basel). 2022 Apr 08;10(4):
pubmed: 35455325
J Adv Nurs. 2022 May;78(5):1366-1376
pubmed: 34806202
Pediatrics. 2018 Apr;141(4):
pubmed: 29540572
Womens Health Issues. 2016 Jan-Feb;26(1):34-9
pubmed: 26344447
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
Prev Med. 2019 Apr;121:115-120
pubmed: 30776387
JAMA Pediatr. 2018 May 7;172(5):e180016
pubmed: 29507952
Prev Med. 2021 Jul;148:106554
pubmed: 33857561
Hum Vaccin Immunother. 2014;10(7):1807-11
pubmed: 25424786
J Sex Med. 2012 May;9(5):1285-94
pubmed: 22443146
Vaccines (Basel). 2021 Jul 01;9(7):
pubmed: 34358132
MMWR Morb Mortal Wkly Rep. 2021 Sep 03;70(35):1183-1190
pubmed: 34473682
Vaccine. 2021 Jun 23;39(28):3731-3736
pubmed: 34078555
MMWR Morb Mortal Wkly Rep. 2019 Aug 16;68(32):698-702
pubmed: 31415491
Vaccine. 2016 Mar 8;34(11):1331-4
pubmed: 26859240

Auteurs

Ikponmwosa Osaghae (I)

Department of Epidemiology, Human Genetics and Environmental Sciences, The University of Texas Health Science Center at Houston (UTHealth) School of Public Health, Houston, TX, USA.
Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Charles Darkoh (C)

Department of Epidemiology, Human Genetics and Environmental Sciences, The University of Texas Health Science Center at Houston (UTHealth) School of Public Health, Houston, TX, USA.

Onyema Greg Chido-Amajuoyi (OG)

Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Wenyaw Chan (W)

Department of Biostatistics and Data Science, UTHealth School of Public Health, Houston, TX, USA.

Paige Padgett Wermuth (PP)

Department of Management, Policy, and Community Health, UTHealth School of Public Health, Houston, TX, USA.

Mala Pande (M)

Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Sonia A Cunningham (SA)

Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Sanjay Shete (S)

Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH